TNKase (T-N-Kase, tenecteplase), a new thrombolytic for treating heart attacks
July 2000
You'll hear about TNKase (T-N-Kase, tenecteplase), a new thrombolytic for treating heart attacks.
Hoffmann LaRoche has introduced it in the U.S. It's being considered in Canada.
TNKase is a modified version of Activase (alteplase, tPA). It's made by substituting 3 amino acids of the tPA enzyme.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive